Concepts (207)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with ROBIN PARIHAR's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that ROBIN PARIHAR has written about over time.
Antineoplastic AgentsInterferon-gammaAntibodies, MonoclonalInterleukin-12Lymphocyte ActivationKiller Cells, NaturalNeoplasmsCell Line, TumorT-LymphocytesReceptors, Antigen, T-Cell, gamma-deltaImmunotherapy, AdoptiveMyeloid-Derived Suppressor CellsInterleukin-7Xenograft Model Antitumor AssaysTumor MicroenvironmentLeukemia, Myeloid, AcuteHematologic NeoplasmsImmunological SynapsesReceptors, Immunologic
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Antineoplastic Agents | 8 | 2002 | 2011 | April 2005 |
| Interferon-gamma | 13 | 2002 | 2017 | May 2006 |
| Antibodies, Monoclonal | 8 | 2002 | 2017 | February 2007 |
| Interleukin-12 | 12 | 2002 | 2021 | September 2008 |
| Lymphocyte Activation | 5 | 2004 | 2017 | February 2010 |
| Killer Cells, Natural | 22 | 2002 | 2025 | June 2011 |
| Neoplasms | 10 | 2002 | 2025 | December 2013 |
| Cell Line, Tumor | 10 | 2004 | 2025 | December 2014 |
| T-Lymphocytes | 5 | 2006 | 2021 | March 2016 |
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2017 | 2017 | April 2017 |
| Immunotherapy, Adoptive | 7 | 2004 | 2025 | September 2019 |
| Myeloid-Derived Suppressor Cells | 4 | 2019 | 2021 | May 2020 |
| Interleukin-7 | 2 | 2017 | 2025 | August 2021 |
| Xenograft Model Antitumor Assays | 5 | 2017 | 2025 | November 2021 |
| Tumor Microenvironment | 6 | 2019 | 2025 | January 2022 |
| Leukemia, Myeloid, Acute | 1 | 2022 | 2022 | March 2022 |
| Hematologic Neoplasms | 1 | 2023 | 2023 | September 2023 |
| Immunological Synapses | 1 | 2025 | 2025 | September 2025 |
| Receptors, Immunologic | 1 | 2025 | 2025 | September 2025 |
To return to the timeline,
click here.